Circulating monocytes and tumor-associated macrophages express recombined immunoglobulins in glioblastoma patients
Glioblastoma is the most common and malignant brain tumor in adults. Glioblastoma is usually fatal 12-15 months after diagnosis and the current possibilities in therapy are mostly only palliative. Therefore, new forms of diagnosis and therapy are urgently needed. Since tumor-associated macrophages a...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
03 June 2019
|
| In: |
Clinical and translational medicine
Year: 2019, Volume: 8 |
| ISSN: | 2001-1326 |
| DOI: | 10.1186/s40169-019-0235-8 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s40169-019-0235-8
|
| Author Notes: | Svenja Busch, Marina Talamini, Steffen Brenner, Amr Abdulazim, Daniel Hänggi, Michael Neumaier, Marcel Seiz-Rosenhagen and Tina Fuchs |
| Summary: | Glioblastoma is the most common and malignant brain tumor in adults. Glioblastoma is usually fatal 12-15 months after diagnosis and the current possibilities in therapy are mostly only palliative. Therefore, new forms of diagnosis and therapy are urgently needed. Since tumor-associated macrophages are key players in tumor progression and survival there is large potential in investigating their immunological characteristics in glioblastoma patients. Recent evidence shows the expression of variable immunoglobulins and TCRαβ in subpopulations of monocytes, in vitro polarized macrophages and macrophages in the tumor microenvironment. We set out to investigate the immunoglobulin sequences of circulating monocytes and tumor-associated macrophages from glioblastoma patients to evaluate their potential as novel diagnostic or therapeutic targets. |
|---|---|
| Item Description: | Gesehen am 01.10.2019 |
| Physical Description: | Online Resource |
| ISSN: | 2001-1326 |
| DOI: | 10.1186/s40169-019-0235-8 |